Cardio Diagnostics Holdings (CDIO) EBITDA Margin (QoQ) (2023 - 2026)
Cardio Diagnostics Holdings (CDIO) EBITDA Margin (QoQ) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | Cardio Diagnostics Holdings | 6.07 Mn | 480,214.31 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.86 Mn |
| Mar 31, 2026 | -2.54 Mn |
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | -3.75 Mn |
| Jun 30, 2025 | 15.10 Mn |
| Mar 31, 2025 | -13.99 Mn |
| Dec 31, 2024 | -1.22 Mn |
| Sep 30, 2024 | -511,732.00 |
| Jun 30, 2024 | 980,972.00 |
| Mar 31, 2024 | 293,424.00 |
| Dec 31, 2023 | -1.46 Mn |
| Sep 30, 2023 | 13.36 Mn |